FDA sent 12 warning letters and five advisory letters earlier this month to companies the regulator said are selling dozens of products that contain unapproved drugs or make illegal claims for treating Alzheimer’s and other serious ailments.
FDA rebukes 17 firms for selling Alzheimer's drugs illegally
Post a Comment